L yell disease, commonly referred to as toxic epidermal necrolysis (TEN), is a rare, lifethreatening condition probably related to drug hypersensitivity; the mortality rate is approximately 30%.
Pathophysiology and Clinical Manifestations
The pathophysiological changes in TEN are due to an autoimmune reaction against epithelial cells, 4 usually triggered by the ingestion of a drug. Erythema multiforme, Stevens-Johnson syndrome (SJS), and TEN are considered part of the same pathological spectrum but can be differentiated clinically (Table 1) . So far the mechanism behind the massive apoptosis of keratinocytes that underlies the common basis of these 3 conditions has not been fully elucidated. Currently Fas-mediated pathways, granulysin, and reactive oxygen species are being investigated as possible early steps in TEN. 7 The clinical picture may begin with unspecific signs and symptoms such as fever, cough, rhinorrhea, or malaise followed by the appearance of unevenly shaped, macular, erythematous lesions on the face and trunk that spread to the extremities and later coalesce. Massive epidermal detachment ensues over the next 5 to 7 days, and reepithelialization occurs during the following weeks. 2 The genitourinary, gastrointestinal, and ocular mucosal surfaces may undergo erosion and ulceration. Histological examination of a skin biopsy may greatly accelerate the diagnosis. Overall mortality rates are about 25% to 35%. 1 In a large retrospective study (47 patients, 11 deaths) of TEN by Yamada et al, 8 sepsis (64%) was the most common cause of death. Other causes included disseminated intravascular coagulation (27%) and liver failure (11%), but the percentages may vary. Nevertheless the majority of deaths are due to sepsis and its complications.
Diagnosis
The diagnosis of TEN is based on clinical findings. The main characteristics are erythematous macules followed by epidermal detachment and blistering, a positive Nicolsky sign, and ulceration of mucosal surfaces. 2 TEN can be distinguished from erythema multiforme, 1 Schneck et al, 5 and Huang et al.
SJS, or SJS-TEN on the basis of the criteria presented in Table 1 . TEN must be differentiated from other autoimmune blistering diseases such as pemphigus vulgaris, bullous pemphigoid, acute generalized exanthema-pustulosis, and, albeit rare, staphylococcal scalded skin syndrome. 1 Histological evidence of necrosis of all epidermal layers in a skin biopsy specimen and the results of direct immunofluorescent staining will exclude most autoimmune conditions and confirm an accurate diagnosis.
Treatment
Optimal treatment for SJS and TEN is a topic of much debate. Because no prospective randomized control trials of various therapeutic options have been completed, no preferred method of treatment has been determined. Although all agree that the first step of any treatment must be identification and discontinuation of the responsible agent, this intervention alone will not stop progression of the disease. Intravenous steroids are the initial treatment of choice of TEN. The primary alternative in resistant cases is intravenous human immunoglobulin (IVIg). 9 However, the results of a recent metaanalysis 6 suggest that IVIg may not be beneficial. The majority of TEN patients in previous studies typically had multiple comorbid conditions that seemed to influence the prognosis much more than the type of treatment used. However, patients who received high doses of IVIg (>2 g/kg) tended to have lower mortality than did patients who received low doses, and infants and children showed improved prognosis regardless of the dose used. 6 Treatment with plasmapheresis has gained support over the years. The filtration of plasma removes the offending autoantibodies from circulating blood. 10 The procedure is performed every second day for a total of 2 to 5 cycles. Plasmapheresis is valued for its rapid results, rare side effects, and efficiency in treating patients with TEN refractory to steroids or IVIg. 8 The results of our own experience 11 and the findings in other case reports, 12 case series, 13 and retrospective cohort studies 8 have consistently indicated clinical benefits with plasmapheresis, and additional research on this method has been recommended. 1, 7 Regardless of the therapeutic option chosen, a comprehensive team approach that emphasizes supportive care is essential for any patient with TEN. Detachment of the epidermal layer results in marked fluid and electrolyte depletion, and loss of the skin's natural barrier properties increases the risk for infection and subsequent sepsis. The possibility of infection and sepsis mandates vigilance throughout the management of patients with TEN. According to recommendations, 14, 15 patients with TEN should be transferred as soon as possible to an intensive care setting, typically a burn unit or a specialized intensive care unit (ICU), where they can receive the required expert wound care. In the case we describe here, the patient was sent to our specialized ICU because the unit's medical team had experience treating TEN, and all necessary resources were available onsite. Close cooperation of the primary care team with members from dermatology, ophthalmology, otolaryngology, rehabilitation, and psychiatry/psychology are essential to achieve a favorable long-term clinical outcome.
Prognosis
The SCORTEN index 16, 17 is a grading scheme used to assess the severity and prognosis of SJS and TEN ( Table 2) . The index can also be used to evaluate the severity of The main characteristics of TEN are erythematous macules followed by epidermal detachment and blistering, a positive Nicolsky sign, and ulceration of mucosal surfaces.
other conditions, such as burns and bullous diseases, that affect the integrity of the skin. The index has 7 criteria: age (>40 years), presence of malignant neoplasm, tachycardia (>120/min), percentage of affected skin surface (>10% total body surface area), serum concentration of urea nitrogen (>10 mmol/L; to convert to milligrams per deciliter, divide by 0.357), serum level of glucose (>250 mg/dL; to convert to milligrams per deciliter, divide by 0.0555), and serum level of bicarbonate (<20 mmol/L). The main differentiating factor between SJS and TEN, an increase in the percentage of skin surface affected by epidermal detachment, has also been associated with increased mortality.
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Case Description
This case description is a detailed account of the supportive therapy delivered during management of TEN in a specialized ICU. We include nursing care during plasmapheresis because the information available on this treatment is insufficient.
A 41-year-old man with a history of hypertension was transferred to the ICU because he had had a rash for 72 hours. A recent upper respiratory infection treated with ciprofloxacin was followed by an acute onset of diffuse maculopapular rash with fluid-filled bullae over the patient's entire body surface. He previously had come to the emergency department when he experienced rapidly progressing changes involving the conjunctivas (hemorrhages, purulent exudates from the conjunctival sac) and oral cavity (ulcerations in mouth, throat, and larynx) within 24 hours after he had ingested 2 doses of ciprofloxacin. Results of dermatology, ophthalmology, and head and neck consultations at this time suggested a diagnosis of TEN.
Upon admission to the ICU, the patient was conscious, verbally responsive, and anxious. Physical examination revealed tachycardia (heart rate 120/min), tachypnea (respirations 20/min), and a low-grade fever (body temperature 37.8ºC). About 80% of his skin surface was covered by a maculopapular, erythematous rash with necrosis, sloughing of the epidermal skin layers, and numerous bullae with underlying ulcerations involving the oral and nasopharyngeal surfaces. The patient said he had throat pain, dysphagia, and dysarthria. He also had periorbital edema, subconjunctival hemorrhages, and purulent exudates from the conjunctival sac. Although cultures of conjunctival exudates were negative for bacterial growth, the patient was given genta micin eye drops as recommended by an ophthalmologist. Ulcerative changes also involved the sclera. Additionally, painful erythematous changes covered the genitalia.
Parenteral nutrition was begun within 24 hours of admission. A nasogastric tube was inserted on day 3, and enteral nutrition was provided from days 3 to 18 in addition to parenteral nutrition. On day 18, liquid oral feedings were begun; parenteral nutrition was used to supplement daily requirements and was slowly tapered off as oral intake increased. Blood glucose levels ranged from 8 to 10 mmol/L; insulin was administered as an infusion. Metoclopramide was used throughout the patient's ICU stay to maintain motility while limiting secretions that could lead to further damage of the mucosa. Pain was treated with an intravenous fentanyl infusion 50 to 100 μg/h plus 100 μg as needed before changing of wound dressings.
An initial continuous infusion of 500 mg of intravenous corticosteroid (methylprednisolone) in saline was begun in the infectious diseases unit before the patient was admitted to the ICU. The lack of improvement after 48 hours of treatment with corticosteroid, rapid progression of the disease, and the need for a fastacting treatment prompted the decision to immediately begin therapeutic plasma exchange (TPE), which has been used to treat patients with steroid-refractory TEN who required rapid improvement. 8, 11 An initial 5-cycle course of TPE was performed (days 1, 2, 4, 5, and 6), and 30 g of IVIg was given after the last cycle. Empirical broad-spectrum antibiotic therapy (ceftriaxone) was started before the patient was admitted to the ICU, and regular electrolyte and fluid replacements were maintained throughout the ICU stay. Treatment with antibiotics (meropenem, vancomycin, colistin) was started after cultures of wound specimens were positive for Streptococcus hemolyticus and blood cultures were positive for gram-positive staphylococci and to prevent infection by organisms present in the ICU.
On day 8, the ICU team diagnosed septic shock. The patient had high body temperature (39°C), unstable hemodynamic condition (mean arterial pressure decreased from 93 mm Hg to 55 mm Hg in 2 hours), and a requirement for continuous vasopressor therapy (intravenous dopamine and norepinephrine). The patient also required supportive oxygen therapy (fraction of inspired oxygen 0.3-0.6). Packed red blood cells, fresh frozen plasma, and 20% albumin solution were administered to counterbalance the hypovolemia, anemia, and hypoalbuminemia due to persistent blood and protein loss during skin sloughing. The purpose of these interventions was to restore intravascular oncotic pressure. The septic shock resolved gradually during the ensuing 5 days. Once the patient's condition was stabilized, reepithelialization began on day 14; the skin color in affected areas began to become pale, and production of exudate decreased.
On day 18, a second period of profuse bleeding (mainly back and buttocks) and exacerbation of fluid losses caused by burrowing of the ulcerations deeper into the dermis began. The patient had a second course of TPE (days 20, 22, 23, and 24) . His clinical picture improved after each subsequent cycle of plasmapheresis. During a period of 4 days, bleeding from the back subsided, the extremities regained turgor, reepithelialization began anew, and ulcerative changes in the oral cavity resolved, in that order. The patient was advanced to a liquid diet, and physical rehabilitation was begun during the fourth week of hospitalization after the skin changes had resolved and only mild discoloration remained ( Figure 1 ). Ophthalmological examination before discharge revealed a healed cornea and retina and normal appearance of the optic nerve. The patient was directed to the allergy and immunology clinic for outpatient follow-up care.
Supportive Therapy
For wound care, dressings impregnated with 0.5% silver nitrate were applied to the entire body except the catheter insertion sites. These sites were a challenge because tape could not be used on them. Therefore they were covered with antiseptic dressings impregnated with povidone-iodine, and the dressings were covered with sterile gauze pads ( Figure 2) . Sloughing of such a large proportion of skin resulted in the loss of the body's main mechanism of thermoregulation. The use of moist dressings contributed to the progressive decrease in body temperature. In order to compensate, a layer of synthetic cotton was added over the dressing to provide increased insulation. Warming blankets were also an effective tool in maintaining appropriate body temperature. The patient's room was put under strict climate control at 30ºC to 32ºC. A stringent schedule of wound dressing changes was put into effect, with a minimum of 3 nurses participating at any single time at least twice daily. The use of 3 nurses decreased the amount of time required and also minimized the need for movement by the patient. The nursing team concentrated on preventing pressure ulcers by using an air-fluidized mattress while preventing contact between skin surfaces of affected body parts, maintaining elevation of the extremities, and changing the patient's body position at least every 2 to 3 hours.
Bleeding and ulcerating lesions on the lips were covered with nonstick paraffin dressings. Oral ulcerations were treated with application every 8 hours of ointment enriched with vitamins A and E. Inflammation in the oral cavity was controlled by rinsing the mouth with 1% chlorhexidine every 6 hours and applying topical benzydamine. The nose, which required particular attention, was treated with frequent debridement of sloughed tissue followed by moisturizing with sterile water. The eyes were treated with antibiotic eye drops (tobramycin), topical fludrocortisone, dexpanthenol gel, and artificial tears.
On day 13, wound care was modified. First, hydrophobic polyamide nets with silver adjuvant (Atrauman Ag) were applied to regions with deep ulcerations; these dressings primarily promote skin healing and regeneration. The nets are also impregnated with a triglyceride coating that keeps the wound margins soft and supple, prevents pruning of skin, and minimizes trauma during dressing changes. Second, dressings made of synthetic cotton wool with ionic silver (Aquacel Ag) were used in areas with heavy secretions because the dressings absorb large amounts of bacteria-filled fluid and can be applied for up to 7 days at a time (manufacturer recommendations). Use of these dressings minimized the frequency of skin trauma caused by dressing changes. Also, the patient was bathed regularly with a solution of ethacridine lactate (Rivanol), and additional ethacridine lactate ointment was applied to all extremities. In addition, the corneal sac was flushed with sterile physiological saline, and compression pads impregnated with sterile physiological saline were placed over the eyes. These interventions improved the patient's comfort during application of ointments and eye drops without damaging local tissues and even allowed him to open his eyes. Table 3 is a summary of supportive strategies for management of TEN.
Maintaining a continual dialogue with the patient and his family was a crucial part of supportive care. The major communication points are highlighted in Table 4 . Provision of emotional support addressed the patient's fears and anxieties, improved his compliance with daily nursing care, and eventually allowed the team to educate him about self-care after discharge.
Discussion
An experienced nursing team, working in a specialized ICU was able to provide thorough supportive therapy as Plasmapheresis is valued for its rapid results, rare side effects, and efficiency in treating patients with TEN refractory to steroids or IVIg. Hydration of the eyelids improves the patient's ability to maintain oculomotor and eyelid movements, facilitating application of ointments and eyedrops to conjunctivae
Nursing intervention
Early detection of increased gastrointestinal bleeding is essential for directing further therapy Pharmacological prevention of stress ulcers is necessary in all patients Prevention of upper respiratory tract infections reduces respiratory effort Humidification of airways prevents formation of hemorrhaging scabs
Patient is at increased risk for infection risk because of the breakdown of the skin's natural barrier function Use of aseptic technique eliminates other potential sources of infection, including venous insertion sites, nasogastric tubes, urinary catheters Hyperglycemia in a nondiabetic patient, also known as hyperglycemic stress, has been linked with a higher likelihood of infections 22 Relief of pain helps prevent stress-induced sympathetic responses that may induce tachycardia, increased blood pressure, increased myocardial oxygen demand, hypercoagulability, insulin resistance, and protein metabolism Use of opioids for analgesic purposes may result in difficulties in respiration and disturbances in consciousness Informing the patient helps alleviate unexpected pain caused by movements during bedside interventions Continuous water and serum loss occurs due to damage of physical skin barrier requires constant assessment Skin changes may impede using a shoulder cuff to measure blood pressure
Continued
Problem
Epidermal detachment
Oral cavity ulceration
Conjunctival ulceration
Gastrointestinal ulceration
Respiratory tract ulceration
Infections and sepsis
Pain
Fluid and electrolyte loss comprehensive meta-analysis 6 suggest that survival rates in patients with TEN treated solely with supportive therapy may be similar to those of patients treated with IVIg. An odds ratio of 1.00 (95% CI, 0.57-1.75) in a comparison part of the successful treatment of this TEN patient. Compared with other methods of treatment, meticulous supportive therapy is the sole intervention that consistently improves prognosis. 7 Interestingly, results from the most The decision to use TPE in this patient was timely; the exchange halted the progression of his condition. The patient had a good response to treatment, with signs of improvement after the third cycle of the first series of plasmapheresis and IVIg. However, the skin changes recurred several days after the first combined plasmapheresis cycle had been completed. A second TPE series was performed (without IVIg), and this time resulted in permanent clinical improvement. These results are similar to outcomes in previous reports of therapeutic success in severe, refractory cases of TEN treated with plasmapheresis. [10] [11] [12] [13] The reason for the outcome is unclear. Researchers speculate that plasmapheresis removes necrosis-inducing factors from the bloodstream, but these factors have yet to be identified. Only a few investigators have examined this topic in detail. A large-scale (47 patients) study of plasmapheresis treatment and TEN by Yamada et al 8 revealed that even a low number of cycles (mean, 3.1) had good efficacy (80.9%), and mortality (23.4%) was lower than predicted in patients with the most severe and resistant form of SJS or TEN. A major difficulty limiting further study of this treatment method is the low incidence of TEN, a situation that results in few patients who could potentially be included in prospective studies.
Nursing intervention
Useful articles [23] [24] [25] on wound care management in TEN patients have been published. But no clear guidelines or even case reports with practical recommendations for delivery of nursing care to patients undergoing plasmapheresis are available. Several important aspects must be addressed to provide appropriate supportive therapy to patients being treated with TPE instead of steroid or IVIg therapy. 26 First, surveillance of hemodynamic parameters is crucial. Either continuous monitoring or checking manually every 15 minutes or so is needed to detect periods of hypotension due to third spacing, which may develop suddenly during TPE procedures. Second, watching for and asking about neurological symptoms such as numbness, tingling, and level of consciousness are important. Such symptoms often indicate the beginning of electrolyte disturbances such as hypocalcemia, hypokalemia, and hypomagnesemia. Third, scrutinizing the patient for possible allergic reactions to blood products, cannulas, or extracorporeal equipment is also important. Fourth, bleeding complications are common because of the use of a large-bore catheter, the large amounts of heparin used, depletion of coagulation factors, and mechanical hemolysis. 22 Such complications must be detected early, and treatment must be altered 
Topics
Discussion of overnight progress and daily plan of care Warning the patient before any nursing duties are begun to reduce anxiety and increase subjective pain threshold Future quality-of-life issues related to vision loss: need for vision correction, use of artificial tears, changes to current lifestyle, living arrangements, need for home care Access to community resources for assistance with rehabilitation Access to social care programs that assist in employment opportunities for people with disabilities Emotional support such as explaining nature of the disease, discussing the prognosis, and assuring them that the patient is receiving the best of care Discussion of long-term complications related to vision loss such as difficulty reading or driving at night, feeling of dryness in eye Offer of professional psychological support for concerns such as dealing with grief, anger, misunderstanding of disease impact Regular follow-up visits with ophthalmologist, dermatologist, internist Instructions for use of artificial tears in case of dry-eye symptoms Avoidance of sunbathing because of harmful effects of ultraviolet rays Avoidance of using a sauna because of the vasodilatory effect of extreme heat on already fragile capillaries Avoidance of sulfonamide-type drugs because of the danger of future cutaneous drug reactions 
Conclusion
TEN is a severe and rare condition that occurs via a mostly unknown pathophysiological mechanism. The high mortality rate makes management a serious challenge for both physicians and nurses. The conflicting evidence on whether steroids or IVIg is the superior treatment accentuates that meticulous supportive therapy and expert wound care are still the major factors contributing to increased survival. Supportive therapy and expert wound care are especially needed when alternative treatments, such as plasmapheresis, are used. Reporting of effective supportive therapy strategies is essential to ensure that future cases will be successfully managed. 
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Several important aspects must be addressed to provide appropriate supportive therapy to patients being treated with therapeutic plasma exchange (TPE) instead of steroid or IVIg therapy.
• First, surveillance of hemodynamic parameters is crucial. Either continuous monitoring or checking manually every 15 minutes or so is needed to detect periods of hypotension due to third spacing, which may develop suddenly during TPE procedures.
• Second, watching for neurological symptoms such as numbness, tingling, and level of consciousness are important. Such symptoms often indicate the beginning of electrolyte disturbances such as hypocalcemia, hypokalemia, and hypomagnesemia.
• Third, scrutinizing the patient for possible allergic reactions to blood products, cannulas, or extracorporeal equipment is also important.
• Fourth, bleeding complications are common because of the use of a large-bore catheter, the large amounts of heparin used, depletion of coagulation factors, and mechanical hemolysis.
• Finally, scrupulous record keeping of all signs and symptoms, laboratory results, medications, and hemodynamic parameters is of paramount importance, especially when electronic health records are not available.
Conclusions
TEN is a severe and rare condition that occurs via a mostly unknown pathophysiological mechanism. The conflicting evidence on whether steroids or IVIg is the superior treatment accentuates that meticulous supportive therapy and expert wound care are still the major factors contributing to increased survival. Supportive therapy and expert wound care are especially needed when alternative treatments, such as plasmapheresis, are used. Reporting of effective supportive therapy strategies is essential to ensure that future cases will be successfully managed. CCN
Facts
Toxic epidermal necrolysis (TEN) is a rare, lifethreatening condition probably related to drug hypersensitivity. The disease is characterized by an initial pruritic, erythematous rash followed by the appearance of bullae, which lead to ulceration and sloughing of the underlying epidermal base similar to physiological damages caused by burns.
• TEN causes crusting, desquamation, and ulceration of the mucous membranes in the oral, ocular, and genital mucosa. Bleeding from internal mucous membranes can progress to hypovolemia and lead to death. • TEN is often accompanied by ocular manifestations that can lead to permanent loss of vision.
• The diagnosis of TEN is based on clinical findings: erythematous macules, epidermal detachment and blistering, a positive Nicolsky sign, and ulceration of mucosal surfaces.
• Intravenous steroids are the initial treatment of choice of TEN. The primary alternative is intravenous human immunoglobulin (IVIg).
• Treatment with plasmapheresis has gained support. The filtration of plasma removes the offending autoantibodies from circulating blood. Plasmapheresis is valued for its rapid results, rare side effects, and efficiency in treating patients with TEN refractory to steroids or IVIg.
• A comprehensive team approach that emphasizes supportive care is essential. Detachment of the epidermal layer results in marked fluid and electrolyte depletion, and loss of the skin's natural barrier properties increases the risk for infection and subsequent sepsis.
• Meticulous supportive therapy is the sole intervention that consistently improves prognosis.
• Patients with TEN should be transferred as soon as possible to an intensive care setting, typically a burn unit or a specialized intensive care unit. 
